A Phase 3, open label extension study assessing the long-term (≥100 EDs) efficacy and safety of BAY 81-8973 in paediatric previously treated patients with severe haemophilia A: LEOPOLD Kids extension study
Latest Information Update: 30 Jun 2021
At a glance
- Drugs Octocog alfa (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Acronyms LEOPOLD Kids extension
- 30 Jun 2021 New trial record